SCYNEXIS (SCYX) 10-Q2024 Q1 Quarterly report

Filed: 8 May 24, 4:01pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: binding, chemistry, disagree, federal, introduced, lift, lifted, memorandum, MOU, observational, optimal, platform, previously, producing, prove, purported, relaunch, restart, resumption, segment, shareholder, single, sooner, state, successor, unbilled, understanding, vigorously, wrong

Removed: aged, aging, Aspire, ATM, bankruptcy, breach, CANDLE, Cantor, ceased, characterized, collective, committee, concentrated, consisting, Controlled, convenience, coordinate, dated, discretion, division, earliest, endpoint, entirety, entry, established, Europe, expensed, expiration, expire, expired, facility, Fitzgerald, funded, fungi, generated, generic, government, history, investment, joint, Journal, Ladenburg, Measurement, monitoring, negotiation, OfferingSM, permitted, policy, Prime, profile, promoting, promotion, quality, rated, receiving, repay, require, ROFN, safety, secured, sell, Street, submission, supportable, SVB, terminate, termination, Thalmann, tranche, type, uncollectibility, uncollectible, uncured, Wall, workforce

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

SCYX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), David Angulo, Chief Executive Officer of SCYNEXIS, Inc. (the “Company”), and Ivor Macleod, Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:

The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2024, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and

The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

In Witness Whereof, the undersigned have set their hands hereto as of May 7, 2024.



/s/ David Angulo, M.D.				/s/ Ivor Macleod
David Angulo, M.D. Chief Executive Officer				Ivor Macleod Chief Financial Officer

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of SCYNEXIS, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.